Covered recipient · General Payments record
ELIJAH N GILBERT
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$1,993.69
- Reported across 103 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $290.97 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Evofem Biosciences, Inc. | $67.25 | 4 |
| PFIZER INC. | $58.82 | 3 |
| Astellas Pharma US Inc | $47.99 | 2 |
| Biogen, Inc. | $46.11 | 2 |
| Sumitomo Pharma America, Inc. | $18.95 | 1 |
| Novo Nordisk AS | $15.90 | 1 |
| Aspira Women's Health Inc | $13.95 | 1 |
| Minerva Surgical, Inc | $13.41 | 1 |
| Organon LLC | $8.59 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aspira Women's Health Inc | $13.95 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126781754 | CMS |
| Astellas Pharma US Inc | $22.42 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139335766 | CMS |
| Astellas Pharma US Inc | $25.57 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139430536 | CMS |
| Biogen, Inc. | $19.51 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104828352 | CMS |
| Biogen, Inc. | $26.60 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104872064 | CMS |
| Evofem Biosciences, Inc. | $16.59 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091278636 | CMS |
| Evofem Biosciences, Inc. | $21.55 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091278626 | CMS |
| Evofem Biosciences, Inc. | $15.03 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091278633 | CMS |
| Evofem Biosciences, Inc. | $14.08 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091278630 | CMS |
| Minerva Surgical, Inc | $13.41 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085612265 | CMS |
| Novo Nordisk Inc | $15.90 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097723517 | CMS |
| Organon Llc | $5.94 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136274172 | CMS |
| Organon Llc | $2.65 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136274176 | CMS |
| PFIZER INC. | $20.44 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131632220 | CMS |
| PFIZER INC. | $18.70 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131754126 | CMS |
| PFIZER INC. | $19.68 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131632224 | CMS |
| Sumitomo Pharma America, Inc. | $18.95 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148855929 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.